Doximity insider: Timothy Cabral receives 3,221 RSUs under director plan

Rhea-AI Filing Summary

Timothy S. Cabral, identified as a director of Doximity, Inc. (DOCS), was granted 3,221 restricted stock units (RSUs) on 08/28/2025 under the company’s non-employee director compensation policy. Each RSU is a contingent right to one share of Class A Common Stock and was granted at no cash price ($0). The RSUs vest in full on the earlier of the first anniversary of the grant date or the issuer’s next annual meeting of stockholders, subject to continued service as a director. After the grant, the reporting person beneficially owned 9,581 shares of Class A Common Stock.

Positive

• Alignment with shareholders: RSUs tie director compensation to company equity and vest contingent on continued service
• Transparent disclosure: Form 4 clearly states grant size (3,221 RSUs) and resulting beneficial ownership (9,581 shares)

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine equity grant to a director; modest ownership increase with standard vesting conditions, limited near-term financial impact.

The grant of 3,221 RSUs to a non-employee director is a common element of outside-director compensation and was recorded at a $0 per-unit price, indicating a service-based equity award rather than a cash purchase. Vesting is time- and event-based (earlier of one year or next annual meeting), aligning the director’s interests with shareholders for the short term. The post-grant beneficial ownership of 9,581 Class A shares provides a disclosure of current stake but does not, by itself, indicate a material change to capital structure or control.

Corporate Governance Expert

TL;DR: Governance-standard RSU award with customary vesting tied to continued service and the next shareholder meeting.

The award follows a non-employee director compensation policy and uses RSUs that convert one-for-one into Class A Common Stock upon vesting, which is standard governance practice to incentivize retention and alignment. The earlier-of vesting schedule (one year or next annual meeting) is typical for director grants. The disclosure transparently states the nature of the award and resulting beneficial ownership, meeting Section 16 reporting requirements and providing clarity on potential future dilution timing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cabral Timothy S

(Last) (First) (Middle)

C/O DOXIMITY, INC.

500 THIRD STREET

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/28/2025		A		3,221(1)	A	$0	9,581	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units (each, an "RSU") granted on August 28, 2025 pursuant to the Issuer's non-employee director compensation policy, which vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Remarks:

	/s/ Anna Bryson, Attorney-in-Fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DOCS director Timothy S. Cabral receive?

He was granted 3,221 RSUs under the issuer's non-employee director compensation policy.

When do the RSUs vest for DOCS director grants?

The RSUs vest in full on the earlier of the first anniversary of the grant date or the issuer's next annual meeting of stockholders, subject to continued service.

What is the price paid for the RSUs reported on the Form 4 for DOCS?

The reported price per RSU is $0, indicating a service-based equity grant.

How many Class A shares does the reporting person beneficially own after the transaction?

The Form 4 reports beneficial ownership of 9,581 shares of Class A Common Stock following the grant.

What does each RSU represent in this filing?

Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon vesting.